Stévenaert A, Perrin G, Martin D, Beckers A
Service de Neurochirurgie, Centre Hospitalier Universitaire, Liege, France.
Neurochirurgie. 2002 May;48(2-3 Pt 2):234-65.
Between November 1994 and June 2001, 194 patients with Cushing's disease underwent transsphenoidal surgery: 167 patients had adenomectomy, 14 had ante hypophysectomy, 5 had subtotal hypophysectomy, 4 had hemihypophysectomy 4 had central hypophysectomy. Complications occurred in 18 patients (9.3%), including 4 deaths (three were apparently not related to surgery). Remission of disease was achieved in 162 of 190 (85.3%) patients analyzed. Surgical failures were associated with lack of pituitary adenoma, size of the tumor and invasiveness. Among patients with confirmed adenomas, the rate of remission was significantly higher (p<0.01) in patients with microadenomas (92.6%) than in patients with macroadenomas (66.7%). Reoperation in 6 failures was followed by remission in 4 cases. The overall remission rate was 87.4%. In the 162 patients with immediate success, duration of follow-up was 10.0 +/- 5.9 years (m +/- DS; median=10.0). Recurrence of the disease occurred in 24 (14.8%) of 162 patients at a mean 4.8 years (range: 0.8-12.0 years). Our longest sustained remission is 25.6 years. Actuarial analysis indicates that the probability of a patient remaining well 12 years after surgery is 80.0%. It is 86.2% in microadenomas versus 52.5% in macroadenomas and 94.5% in the patients with postoperative hypocortisolism versus 59.2% in the others.
1994年11月至2001年6月期间,194例库欣病患者接受了经蝶窦手术:167例行腺瘤切除术,14例行垂体前叶切除术,5例行垂体次全切除术,4例行垂体半切除术,4例行垂体中央部切除术。18例患者(9.3%)出现并发症,其中4例死亡(3例显然与手术无关)。在分析的190例患者中,162例(85.3%)疾病缓解。手术失败与垂体腺瘤缺失、肿瘤大小及侵袭性有关。在确诊为腺瘤的患者中,微腺瘤患者的缓解率(92.6%)显著高于大腺瘤患者(66.7%)(p<0.01)。6例手术失败患者再次手术后,4例缓解。总体缓解率为87.4%。162例即刻手术成功的患者,随访时间为10.0±5.9年(均值±标准差;中位数=10.0)。162例患者中有24例(14.8%)疾病复发,平均复发时间为4.8年(范围:0.8 - 12.0年)。我们最长的持续缓解时间为25.6年。精算分析表明,患者术后12年病情保持良好的概率为80.0%。微腺瘤患者为86.2%,大腺瘤患者为52.5%,术后出现肾上腺皮质功能减退的患者为94.5%,其他患者为59.2%。